Great concept, have some interesting members aboard but its not looking so good for cbis. They havent completed any actual research or product development- its all preliminary stages. Also they ate located in CO but are trying to establish themselves in Europe to create these meds- which is wierd considering in 3 months CO will be legalized and the FDA is accepting applications n patents from other companies - like Nuvilex and GW pharm.
Cannameds work, the future is here but the odds r stacked against CBIS unfortunately- esp in an industry where cash is king- big pharm has alot, cbis not so much. Goodluck tho
Market Data 
Markets 
AI
